VOR BIOPHARMA INC (VOR) Stock Overview
USA - NASDAQ:VOR - US9290331084 - Common Stock
VOR Key Statistics, Chart & Performance
The current stock price of VOR is 27.24 USD. In the past month the price decreased by -37.23%. In the past year, price increased by 51.33%.
VOR Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 21.01 | 393.01B | ||
| AMGN | AMGEN INC | 13.09 | 153.65B | ||
| GILD | GILEAD SCIENCES INC | 14.74 | 141.56B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.62 | 98.23B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.97 | 62.75B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 59.45B | ||
| ARGX | ARGENX SE - ADR | 79.48 | 45.09B | ||
| ONC | BEONE MEDICINES LTD-ADR | 5.84 | 39.75B | ||
| INSM | INSMED INC | N/A | 30.60B | ||
| NTRA | NATERA INC | N/A | 24.86B | ||
| BNTX | BIONTECH SE-ADR | N/A | 23.13B | ||
| BIIB | BIOGEN INC | 8.9 | 20.89B |
Related stock screener links
About VOR
Company Profile
Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. The company is headquartered in Cambridge, Massachusetts and currently employs 159 full-time employees. The company went IPO on 2021-02-05. The firm is focused on rapidly advancing telitacicept, a dual-target fusion protein, through Phase III clinical development and commercialization to address serious autoantibody-driven conditions worldwide. Telitacicept is an investigational recombinant fusion protein designed to treat autoimmune diseases by selectively inhibiting BLyS (BAFF) and APRIL - two cytokines essential to B cell and plasma cell survival. This dual-target mechanism reduces autoreactive B cells and autoantibody production, key drivers of autoimmune pathology. Telitacicept is approved in China for systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and generalized myasthenia gravis (gMG). A global Phase III clinical trial in gMG is underway across the United States, Europe, and South America to support potential approval in the United States and Europe.
Company Info
VOR BIOPHARMA INC
100 Cambridgepark Drive, Suite 101
Cambridge MASSACHUSETTS US
Employees: 159
Phone: 16176556580
VOR BIOPHARMA INC / VOR FAQ
What is the stock price of VOR BIOPHARMA INC today?
The current stock price of VOR is 27.24 USD. The price decreased by -10.39% in the last trading session.
What is the ticker symbol for VOR BIOPHARMA INC stock?
The exchange symbol of VOR BIOPHARMA INC is VOR and it is listed on the Nasdaq exchange.
On which exchange is VOR stock listed?
VOR stock is listed on the Nasdaq exchange.
What is VOR BIOPHARMA INC worth?
VOR BIOPHARMA INC (VOR) has a market capitalization of 3.45B USD. This makes VOR a Mid Cap stock.
How many employees does VOR BIOPHARMA INC have?
VOR BIOPHARMA INC (VOR) currently has 159 employees.
What are the support and resistance levels for VOR BIOPHARMA INC (VOR) stock?
VOR BIOPHARMA INC (VOR) has a resistance level at 37.83. Check the full technical report for a detailed analysis of VOR support and resistance levels.
Should I buy VOR BIOPHARMA INC (VOR) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of VOR, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of VOR, evaluating the profitability, health, valuation and growth aspects
- VOR BIOPHARMA INC (VOR) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- VOR BIOPHARMA INC (VOR) Sales and EPS estimates to see what analysts future expectations are.
- VOR BIOPHARMA INC (VOR) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- VOR BIOPHARMA INC (VOR) Insider and Institutional Ownership to learn about the owners and their transactions.
- VOR BIOPHARMA INC (VOR) Stock Chart to make your own analysis
- VOR BIOPHARMA INC (VOR) Latest news and press-releases to stay up to date.
Does VOR BIOPHARMA INC (VOR) stock pay dividends?
VOR does not pay a dividend.
When does VOR BIOPHARMA INC (VOR) report earnings?
VOR BIOPHARMA INC (VOR) will report earnings on 2025-11-05, after the market close.
What is the Price/Earnings (PE) ratio of VOR BIOPHARMA INC (VOR)?
VOR BIOPHARMA INC (VOR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.29).
What is the Short Interest ratio of VOR BIOPHARMA INC (VOR) stock?
The outstanding short interest for VOR BIOPHARMA INC (VOR) is 25.64% of its float. Check the ownership tab for more information on the VOR short interest.
VOR Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to VOR. When comparing the yearly performance of all stocks, VOR is one of the better performing stocks in the market, outperforming 98.81% of all stocks.
VOR Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to VOR. VOR has a bad profitability rating. Also its financial health evaluation is rather negative.
VOR Financial Highlights
Over the last trailing twelve months VOR reported a non-GAAP Earnings per Share(EPS) of -3.29. The EPS decreased by -89.08% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -810.45% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |